MUST WATCH: President Trump Hilariously Roasts Mark Cuban During…

Mark Cuban, the billionaire entrepreneur who spent years calling Donald Trump the most unethical person he had ever done business with, who stumped for Kamala Harris on the 2024 campaign trail, and who took every available opportunity to position himself as the respectable face of anti-Trump business culture, stood Monday at the White House podium, grinning beside the president he once despised, and announced himself as one of the biggest proponents of TrumpRx in the country. The president, for his part, could not resist the moment.

A reporter at the White House event noted the awkward history directly, pointing out to Trump that “Mark endorsed Kamala Harris back in 2024.” Trump’s response was immediate, cheerful, and utterly without mercy: “Well, he made a mistake. It was a big mistake.” Cuban, standing just behind the president, laughed. The room laughed. And somewhere in that brief exchange, the entire political theater of the 2024 election cycle was punctured with a single line that the president delivered with the ease of a man who knew exactly what he was doing.

Cuban appeared happy to promote TrumpRx from the podium, telling the assembled crowd: “I think other than you, I’ve been the biggest proponent of TrumpRx.com.” He framed the initiative as a rare point of genuine national agreement: “Republicans want cheaper drugs, independents want cheaper drugs, Democrats want cheaper drugs. And together I think we’re going to do something special.”

It was a straightforward, bipartisan pitch for a policy that has no natural enemies among ordinary Americans, which is exactly the kind of political terrain that the Trump administration has been methodically claiming since returning to office.

The White House event marked a significant expansion of the TrumpRx initiative, with the administration announcing the addition of more than 600 generic drugs through partnerships with GoodRx, Amazon Pharmacy, and Cost Plus Drugs. Trump further revealed that the website has been visited over 10 million times and has saved users more than $400 million.

Those numbers are not abstractions. They represent real American families, real prescriptions filled at lower prices, and real savings that have landed in people’s pockets rather than in the profit margins of the pharmaceutical industry. The president has made no secret of his desire to break Big Pharma’s grip on American drug pricing, and the TrumpRx numbers suggest the effort is gaining traction with the public.

Cuban’s Cost Plus Drug Company contributed directly to that expansion, with 559 of the roughly 600 newly listed generic medications coming from his company. Cuban boasted about the “special partnership” with TrumpRx, describing it as the product of a shared commitment to lowering the cost of healthcare for all Americans regardless of party affiliation.

The business logic is not complicated: Cuban built Cost Plus Drugs precisely to undercut the traditional pharmacy pricing model, and TrumpRx is a distribution and visibility channel that sends American consumers directly to his platform. The partnership serves the policy goal and the bottom line simultaneously, which is generally how durable alliances get built.

The backstory of this particular alliance is worth dwelling on at length, because it is a case study in what happens when the performance of political opposition collides with the practical reality of policy results. Mark Cuban is not a man who arrived at the White House on Monday without a history. He spent the better part of a decade constructing a public persona as one of Trump’s most prominent and credible critics from within the business world. He was visible, quotable, and reliable.

When Trump’s opponents wanted a successful businessman who would say on television that Trump was bad for business, bad for the country, and bad for the culture, Cuban was available and willing.

When asked directly whether he regretted supporting Kamala Harris on the campaign trail, Cuban shut the door: “I’m not going into my politics at all.” That is the statement of a man who has concluded, at least for now, that the political chapter of his public life is a liability rather than an asset, and that the healthcare chapter is where his energy and his legacy are better invested.

It is a reasonable calculation. It is also, whether Cuban would acknowledge it or not, a quiet concession that the political choices he made in 2024 did not produce the outcomes he wanted for the country.

When asked at Politico’s Health Care Summit last month about whether he wants Kamala Harris to run for president again, Cuban said simply: “No.” When asked to recall her message on health care during the 2024 election, he offered this: “Don’t remember, don’t care.”

That is not the language of a man who believes the candidate he campaigned for was robbed of a historic victory by a rigged system. That is the language of a man who has moved on and would prefer the rest of the conversation move on with him.

President Trump was not entirely inclined to let the past dissolve entirely, but he was generous in the way that a man tends to be generous when he has already won. When asked what Cuban’s presence at the White House said about what they were building together, Trump replied without hesitation: “It says we love people, we love our country. He’s got a good company, and he’s going to do a lot of business with us.” He added that he has “a lot of respect for Mark, frankly,” and that he “always has.”

The sentiment was gracious without being sentimental, the kind of thing a confident man says when the outcome of an argument has already been settled.

The TrumpRx initiative itself deserves to be understood on its own terms, separate from the political theater surrounding Cuban’s appearance. The program is a straightforward attempt to use the visibility and credibility of the presidency to direct American consumers toward lower-cost pharmaceutical options that already exist in the marketplace but that many people simply do not know about or have not been systematically pointed toward. The administration is not creating new drugs or building new supply chains.

It is building an on-ramp to lower prices that the industry’s existing pricing structures have made it difficult for ordinary people to find on their own. Whether one likes the president or not, the proposition that Americans should pay less for their medications is not a controversial one, which is precisely why Cuban was willing to stand beside Trump to say so.

The partnership between the White House and Cost Plus Drugs also represents a meaningful policy alignment between an administration that has consistently pushed back against pharmaceutical industry pricing and a company that was built on exactly the same premise.

Cuban launched Cost Plus Drugs in 2022 on the explicit argument that the traditional pharmacy benefit manager model had inflated drug prices far beyond what the underlying economics of manufacturing and distribution required. The company sells drugs at cost plus a 15 percent markup, a $5 dispensing fee, and $5 shipping, a pricing model so transparent and so much lower than the traditional retail pharmacy price on many medications that it effectively shames the incumbent industry every time someone looks up a drug on the platform.

The political symbolism of the day was not lost on anyone in the room. The Democratic Party spent the 2024 election cycle presenting itself as the party of competent, reasonable governance and healthcare affordability, with Cuban as one of its most prominent validators of business.

Less than two years later, that same Cuban is standing in the Trump White House, describing himself as TrumpRx’s biggest proponent after the president himself, while the Democratic candidate he campaigned for cannot be recalled by name or policy when asked directly. That is not a minor footnote to the 2024 election. It is a data point about which party’s healthcare agenda has actually produced something tangible for American consumers.

Cuban’s appearance at the event was not without friction inside his own corner of the internet. He deleted a social media post after backlash from his progressive following over his decision to partner with the Trump administration. The deletion drew more attention than the original post, as deletions usually do, and briefly turned the story from one about drug prices to one about whether Cuban could survive the political consequences of being photographed standing next to the President.

That his followers responded to a healthcare affordability initiative with enough outrage to compel him to delete a post says something unflattering about the state of progressive politics, where the instinct to punish those who cooperate with the other side apparently extends even to policies that lower the cost of prescription medications.

Cuban’s answer to that backlash, delivered in an email to the Daily Beast, was pointed: “I care about lowering the cost of healthcare. The rest is rage bait.” That is a line worth keeping. Whether or not Cuban would ever admit publicly that voting for Kamala Harris was a mistake, the behavior of his own coalition in response to his appearance at a healthcare event suggests he has at least begun to understand the limits of political tribalism as a guide to policy.

When your own supporters are angry at you for helping lower drug prices because it required standing next to the wrong president, it is reasonable to start questioning whose interests that tribalism actually serves.

For conservative Americans who have watched the political and business establishment unite for years to delegitimize this administration and everything it attempts, Monday’s scene at the White House carries a satisfaction that transcends the specific policy on display.

It is not that Mark Cuban has become a Trump supporter. He clearly has not, and he was careful to make that plain the moment the cameras moved outside. What it represents is something more modest and more important: the acknowledgment, implicit if not explicit, that the results of this administration’s work are real enough that even its opponents cannot entirely ignore them.